AFT Pharmaceuticals Ltd (OTCPK:AFTPF)

$ 0 0 (0%) Market Cap: 205.17 Mil Enterprise Value: - PE Ratio: 25.89 PB Ratio: 3.63 GF Score: 90/100

AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 03, 2023
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 01, 2023
Full Year 2023 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 21, 2023

Earnings
Half Year 2023 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 23, 2022

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 04, 2022
Full Year 2022 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 22, 2022

Earnings
Half Year 2022 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 17, 2021

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 05, 2021
Full Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 23, 2021

Earnings
Half Year 2021 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 18, 2020

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Sep 07, 2020
Full Year 2020 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 19, 2020

Earnings
Interim 2020 AFT Pharmaceuticals Ltd Earnings Call Transcript
Nov 20, 2019

Earnings
AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript
Aug 01, 2019
Preliminary 2019 AFT Pharmaceuticals Ltd Earnings Call Transcript
May 21, 2019

Earnings

AFT Pharmaceuticals Ltd Annual Shareholders Meeting Transcript

Sep 07, 2020 / 10:30PM GMT

Transcript

David M. Flacks

AFT Pharmaceuticals Limited - Independent Chairman

Okay. (foreign language) Kia ora and good morning, and welcome to AFT Pharmaceuticals Annual Meeting. I am David Flacks, Chairman of AFT. These are indeed strange times, and following the adjournment of this meeting on the 12th of August, we decided to reschedule with a virtual-only meeting amid the current uncertainty. I would like to thank you all for attending today and for your patience. We'll be using some slides during the meeting, and for those of you online, you'll be able to see these and follow along. They're also available on the NZX and ASX websites as well as on AFT's investor website.

Let me begin by introducing you to your directors. Hartley Atkinson is here with me and he'll be presenting to you shortly. Jon Lamb is online. Doug Wilson is online. Marree Atkinson will also be presenting to you later as she is standing for reelection as a director. And our U.S.-based Director, Jim Burns, of course, is also online. Our auditors, Deloitte, and our legal advisers, HHL, are online and as with the other directors, are

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.